0.8025
전일 마감가:
$0.825
열려 있는:
$0.83
하루 거래량:
871.46K
Relative Volume:
1.41
시가총액:
$32.10M
수익:
-
순이익/손실:
$-35.58M
주가수익비율:
-0.3028
EPS:
-2.65
순현금흐름:
$-42.82M
1주 성능:
-12.45%
1개월 성능:
-22.09%
6개월 성능:
-47.20%
1년 성능:
-35.80%
Iterum Therapeutics Plc Stock (ITRM) Company Profile
명칭
Iterum Therapeutics Plc
전화
(872) 225-6077
주소
3 DUBLIN LANDINGS, DUBLIN 1
ITRM을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ITRM
Iterum Therapeutics Plc
|
0.8025 | 33.00M | 0 | -35.58M | -42.82M | -2.65 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Iterum Therapeutics Plc Stock (ITRM) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2021-05-28 | 업그레이드 | Gabelli & Co | Sell → Hold |
2021-03-15 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
2020-06-02 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
2020-01-21 | 다운그레이드 | Gabelli & Co | Buy → Sell |
2019-12-11 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
2019-06-21 | 개시 | H.C. Wainwright | Buy |
모두보기
Iterum Therapeutics Plc 주식(ITRM)의 최신 뉴스
Iterum Therapeutics plc Stock Analysis and ForecastFree Stock Market Trend Analysis - PrintWeekIndia
Is Iterum Therapeutics plc a good long term investmentSuperior risk-adjusted returns - Autocar Professional
What drives Iterum Therapeutics plc stock priceConsistently exceptional gains - Autocar Professional
Iterum Therapeutics Plc (ITRM) Stock: A Year of Market Movement, Down and Up - investchronicle.com
What analysts say about Iterum Therapeutics plc stockHigh-profit capital plays - jammulinksnews.com
Why Iterum Therapeutics plc stock attracts strong analyst attentionMassive Profit Potential - Newser
What makes Iterum Therapeutics plc stock price move sharplyWatchlist Winner Update - Newser
How Iterum Therapeutics plc stock performs during market volatilityFree Access to Investment Community - Newser
OneDigital Investment Advisors LLC Invests $124,000 in Iterum Therapeutics PLC (NASDAQ:ITRM) - Defense World
Iterum Therapeutics (NASDAQ:ITRM) Trading Down 4.2% – Here’s What Happened - Defense World
Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
Iterum Strengthens Launch Strategy: 30-Year Pharma Veteran Christine Coyne to Lead ORLYNVAH Commercialization - Stock Titan
Iterum Names Christine Coyne as Chief Commercial Officer to Lead ORLYNVAH™ Launch and Commercial Growth - Yahoo Finance
Certain Options of Iterum Therapeutics plc are subject to a Lock-Up Agreement Ending on 30-JUN-2025. - MarketScreener
Certain Ordinary Shares of Iterum Therapeutics plc are subject to a Lock-Up Agreement Ending on 30-JUN-2025. - MarketScreener
Iterum Therapeutics (ITRM) Releases Positive Phase 3 Trial Resul - GuruFocus
Iterum Therapeutics (ITRM) Releases Positive Phase 3 Trial Results | ITRM Stock News - GuruFocus
New Antibiotic Shows Promise Against Drug-Resistant UTIs: NEJM Evidence Reveals 9.2% Multi-Resistance Rate - Stock Titan
Transcript : Iterum Therapeutics plcSpecial Call - MarketScreener
Research Analysts Set Expectations for ITRM FY2026 Earnings - Defense World
Two Sigma Investments LP Invests $45,000 in Iterum Therapeutics plc (NASDAQ:ITRM) - Defense World
EVERSANA expands commercialisation portfolio with OS Therapies and Iterum Therapeutics partnerships - pharmaphorum
Citadel Advisors LLC Acquires Shares of 21,207 Iterum Therapeutics plc (NASDAQ:ITRM) - Defense World
Iterum Therapeutics (ITRM) Partners with EVERSANA for U.S. Launc - GuruFocus
Iterum Therapeutics announces partnership with EVERSANA - PharmaLive
Iterum Therapeutics inks deal for ORLYNVAH commercialization By Investing.com - Investing.com Nigeria
Iterum Therapeutics inks deal for ORLYNVAH commercialization - Investing.com
Iterum Therapeutics Announces Partnership for Commercialization Services - Yahoo Finance
Pfizer grants Iterum payment extension for FDA-approved antibiotic By Investing.com - Investing.com South Africa
Pfizer grants Iterum payment extension for FDA-approved antibiotic - Investing.com Australia
Iterum Therapeutics Plc (ITRM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):